Stem Cell Authority, Ltd. (SCAL)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2002 | 2001 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 4233.00 | 41.31 Thousand | 42.2 Thousand |
| Selling, General and Administrative Expenses | 4233.00 | 1000.00 | 1025.00 |
| Research and Development Expenses | - | - | - |
| Other Expenses | - | -40.31 Thousand | -41.18 Thousand |
| Cost and Expenses | 4233.00 | 41.31 Thousand | 42.2 Thousand |
| Operating Income | -4230.00 | -41.31 Thousand | -42.2 Thousand |
| Interest Expense | - | - | - |
| Income Tax Expense | - | - | - |
| Earnings before Tax | -4233.00 | -41.31 Thousand | -42.2 Thousand |
| Net Income | -4233.00 | -41.31 Thousand | -42.2 Thousand |
| Earnings Per Share Basic | - | -0.01 | -0.01 |
| Earnings Per Share Diluted | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 970.85 Million | 6 Million | 6 Million |
| Weighted Average Shares Outstanding (Diluted) | 970.85 Million | 6 Million | 6 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | -4233.00 | -41.31 Thousand | -42.2 Thousand |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2002 FY | 2001 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 4233.00 | 507.00 | 507.00 | 1719.00 | 41.31 Thousand | 42.2 Thousand |
| Selling, General and Administrative Expenses | - | 507.00 | 507.00 | 1719.00 | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | -40.31 Thousand | -41.18 Thousand |
| Cost and Expenses | 4233.00 | 507.00 | 507.00 | 1719.00 | 41.31 Thousand | 42.2 Thousand |
| Operating Income | -4230.00 | -510.00 | -510.00 | -1720.00 | -41.31 Thousand | -42.2 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -4233.00 | -507.00 | -507.00 | -1719.00 | -41.31 Thousand | -42.2 Thousand |
| Net Income | -4233.00 | -507.00 | -507.00 | -1719.00 | -41.31 Thousand | -42.2 Thousand |
| Earnings Per Share Basic | - | - | - | - | - | - |
| Earnings Per Share Diluted | - | - | - | - | - | - |
| Weighted Average Shares Outstanding | 970.85 Million | 970.85 Million | 970.85 Million | 970.85 Million | 6 Million | 6 Million |
| Weighted Average Shares Outstanding (Diluted) | 970.85 Million | 970.85 Million | 970.85 Million | 970.85 Million | 6 Million | 6 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -510.00 | -510.00 | -1720.00 | - | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
300689
PLLWF
CJGEL
BNYN
EFORL
057050